ImmunoPrecise Antibodies Ltd. (OTCMKTS:IPATF – Get Free Report)’s stock price fell 7.4% on Tuesday . The stock traded as low as $0.39 and last traded at $0.41. 213,862 shares were traded during trading, an increase of 952% from the average session volume of 20,327 shares. The stock had previously closed at $0.44.
ImmunoPrecise Antibodies Stock Performance
The firm has a 50-day moving average price of $0.55 and a 200-day moving average price of $0.81.
About ImmunoPrecise Antibodies
ImmunoPrecise Antibodies Ltd. engages in the provision of human therapeutic antibody discovery and development services. It offers a selection of antibodies, enzymes, enzymes activity assays, arthritis animal products, proteins, deiminated proteins, and hybridoma licensing for research purposes. Its services include B cell sorting, screening and sequencing; custom, immune and naive phage display production and screening; bi-specific, tri-specific, VHH, and VNAR antibody manufacturing; antibody engineering; and antibody optimization and humanization.
Further Reading
- Five stocks we like better than ImmunoPrecise Antibodies
- Russell 2000 Index, How Investors Use it For Profitable Trading
- Why Palo Alto Networks’ Multi-Year Uptrend Is Far From Over
- How to Know if a Stock Pays Dividends and When They Are Paid Out
- 3 Rock-Solid Buying Opportunities in the Market Right Now
- What Percentage Gainers Tell Investors and Why They Don’t Tell the Whole Story
- TJX Companies Stock Poised to Hit a New High This Year
Receive News & Ratings for ImmunoPrecise Antibodies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ImmunoPrecise Antibodies and related companies with MarketBeat.com's FREE daily email newsletter.
